Laboratory of Immunopharmacology and Experimental Therapeutics, Division of Cancer Research, Regional Cancer Centre, Medical College Campus, Thiruvananthapuram 695011, Kerala, India.
Division of Crop Improvement, ICAR-Central Plantation Crops Research Institute, Kasaragod 671124, Kerala, India.
Anticancer Agents Med Chem. 2022;22(1):169-180. doi: 10.2174/1871520621666210322102915.
Although Methotrexate (MTX) possesses a wide clinical spectrum of activity, its toxic side effects on normal cells and drug resistance often hamper its successful outcome. Naringenin (NG) is one of the promising bioactive flavonoids that are extensively found in grapes, citrus fruits, and fruit arils of Pithecellobium dulce.
Only a few experimental in vivo studies on the efficacy of NG against chemotherapeutic drugs have been carried out. Aiming to fill this gap, the present study was carried out to characterize and identify its possible therapeutic targets and also to explore its protective efficacy against MTX-induced tissue damage.
Oxidative stress was induced in mice with MTX (20 mg/kg B.wt), and animals were orally administered with 10 mg/kg B.wt NG for 10 consecutive days. On day 11, all animals were sacrificed, and hematological and serum biochemical parameters were analyzed. The anti-oxidant efficacy of NG against MTX was evaluated by quantifying tissue superoxide dismutase (SOD), glutatione peroxidase (GPx), reduced glutathione (GSH) and catalase along with oxidative stress markers [malondialdehyde (MDA) and nitric oxide (NO)]. Further, the histopathological analysis was performed to confirm the protective efficacy of FPD. In silico docking studies were also performed to exploring anti-oxidant enzyme-based targets.
Our results showed that concurrent administration of NG counteracted oxidative stress induced by MTX, as evidenced by increased expression of anti-oxidant markers, decreased expression of renal and hepatotoxicity serum marker enzymes (p <0.05). A molecular docking study was performed using Auto dock vina to understand the mechanism of ligand binding (S-NG and R-NG)with anti-oxidant enzymes. The binding affinity of S-NG with catalase, GPx, ALP, and SGPT was -10.1, -7.1, -7.1, and -7.3 kcal/mol, respectively, whereas for R-NG was -10.8, -7.1, -7.6, and -7.4 kcal/mol, respectively. Further, histopathological analysis affirmed the protective efficacy of NG against MTX-induced hepatic and renal toxicities.
Treatment with NG significantly reduced MTX-induced pancytopenia, renal, and hepatic toxicity.
甲氨蝶呤(MTX)具有广泛的临床活性谱,但它对正常细胞的毒性副作用和耐药性常常阻碍其成功的结果。柚皮素(NG)是一种很有前途的生物活性类黄酮,广泛存在于葡萄、柑橘类水果和甜豆荚的果实中。
只有少数关于 NG 对抗化疗药物的疗效的实验性体内研究。为了填补这一空白,本研究旨在对其可能的治疗靶点进行特征描述和鉴定,并探讨其对 MTX 诱导的组织损伤的保护作用。
用 MTX(20mg/kg 体重)诱导小鼠产生氧化应激,并用 10mg/kg 体重的 NG 连续 10 天进行口服治疗。第 11 天,所有动物被处死,分析血液学和血清生化参数。通过定量组织中超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GPx)、还原型谷胱甘肽(GSH)和过氧化氢酶以及氧化应激标志物[丙二醛(MDA)和一氧化氮(NO)]来评估 NG 对 MTX 的抗氧化作用。此外,还进行了组织病理学分析以确认 FPD 的保护作用。还进行了计算机对接研究,以探索基于抗氧化酶的靶点。
我们的结果表明,NG 的同时给药抵消了 MTX 诱导的氧化应激,这表现在抗氧化标记物的表达增加,肾毒性和肝毒性血清标记酶的表达减少(p<0.05)。使用 Auto dock vina 进行了分子对接研究,以了解配体结合(S-NG 和 R-NG)与抗氧化酶的机制。S-NG 与过氧化氢酶、GPx、碱性磷酸酶和 SGPT 的结合亲和力分别为-10.1、-7.1、-7.1 和-7.3 kcal/mol,而 R-NG 的结合亲和力分别为-10.8、-7.1、-7.6 和-7.4 kcal/mol。此外,组织病理学分析证实了 NG 对 MTX 诱导的肝和肾毒性的保护作用。
NG 的治疗显著降低了 MTX 诱导的全血细胞减少症、肾和肝毒性。